Comparative effectiveness inventory
This article was originally published in The Gray Sheet
The Department of Health and Human Services is 1requesting public comment through Aug. 9 on development of a comparative effectiveness research "inventory" of ongoing and completed research for public consumption. HHS agencies have posted information on research projects stemming from the $1.1 billion in comparative effectiveness funding provided by economic stimulus legislation (2"The Gray Sheet" Jan. 11, 2010), but the agency is trying to develop a more comprehensive and accessible database. Comments are requested on appropriate sources of research for inclusion in the inventory, incentives for encouraging participation, methods for categorizing content and strategies to ensure that the inventory is "useful and sustainable over time.
You may also be interested in...
The HHS Office of the Assistant Secretary for Planning and Evaluation will be using four primary sources to fill a planned online inventory of comparative effectiveness research.
AdvaMed is encouraging Health and Human Services' efforts to start building a centralized inventory of comparative effectiveness research, even as drug industry groups complain the project would be "premature" before a congressionally established public-private institute gets up and running
The National Institutes of Health handed out about $40 million of its comparative effectiveness research funds in 2009 to studies directly impacting devices, with more than two-thirds of that money targeting medical imaging or in vitro diagnostics applications